These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28746432)

  • 1. Late onset multiple sclerosis: concerns in aging patients.
    Lotti CBC; Oliveira ASB; Bichuetti DB; Castro I; Oliveira EML
    Arq Neuropsiquiatr; 2017 Jul; 75(7):451-456. PubMed ID: 28746432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    Alroughani R; Akhtar S; Ahmed S; Behbehani R; Al-Hashel J
    PLoS One; 2016; 11(11):e0165846. PubMed ID: 27802328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA; Buron MD; Magyari M
    J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.
    Ozakbas S; Kaya E; Aslan T; Ozdogar AT; Baba C
    Mult Scler Relat Disord; 2024 Oct; 90():105810. PubMed ID: 39180837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gender on late-onset multiple sclerosis.
    Bove RM; Healy B; Augustine A; Musallam A; Gholipour T; Chitnis T
    Mult Scler; 2012 Oct; 18(10):1472-9. PubMed ID: 22383227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
    Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of early versus late disability accumulation in primary progressive MS.
    Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
    Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a late-onset multiple sclerosis Portuguese cohort.
    Moura J; Duarte S; Oliveira V; Pereira D; Costa D; Samões R; Sousa AP; Silva AM; Santos E
    Mult Scler Relat Disord; 2023 Feb; 70():104506. PubMed ID: 36638770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
    Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
    Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
    Lorefice L; Ferraro OE; Fenu G; Amato MP; Bresciamorra V; Conte A; De Luca G; Ferraro D; Filippi M; Gazzola P; Iaffaldano P; Inglese M; Lus G; Marfia GA; Patti F; Pesci I; Salemi G; Trojano M; Zaffaroni M; Monti MC; Cocco E;
    J Neurol; 2024 Apr; 271(4):1630-1637. PubMed ID: 38172380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
    Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
    Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
    Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
    Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
    Shirani A; Zhao Y; Kingwell E; Rieckmann P; Tremlett H
    Mult Scler; 2012 Apr; 18(4):442-50. PubMed ID: 21952097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
    Shirani A; Zhao Y; Petkau J; Gustafson P; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Tremlett H
    Biomed Res Int; 2015; 2015():451912. PubMed ID: 25922836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset multiple sclerosis.
    Arias M; Dapena D; Arias-Rivas S; Costa E; López A; Prieto JM; Corredera E
    Neurologia; 2011 Jun; 26(5):291-6. PubMed ID: 21163234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; De Keyser J
    Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability.
    Cerqueira Pinto SC; Ferreira Vasconcelos CC; Aurenção JCK; Alvarenga MP; das Graças Gomes Camargo SM; Santos Thuler LC; Alvarenga RP
    Pediatr Neurol; 2019 May; 94():48-54. PubMed ID: 30850228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.